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Abstract
Background: Multimorbidity is a highly frequent condition in older people, but well designed
longitudinal studies on the impact of multimorbidity on patients and the health care system have
been remarkably scarce in numbers until today. Little is known about the long term impact of
multimorbidity on the patients' life expectancy, functional status and quality of life as well as health
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care utilization over time. As a consequence, there is little help for GPs in adjusting care for these
patients, even though studies suggest that adhering to present clinical practice guidelines in the care
of patients with multimorbidity may have adverse effects.
Methods/Design: The study is designed as a multicentre prospective, observational cohort study
of 3.050 patients aged 65 to 85 at baseline with at least three different diagnoses out of a list of 29
illnesses and syndromes. The patients will be recruited in approx. 120 to 150 GP surgeries in 8
study centres distributed across Germany. Information about the patients' morbidity will be
collected mainly in GP interviews and from chart reviews. Functional status, resources/risk factors,
health care utilization and additional morbidity data will be assessed in patient interviews, in which
a multitude of well established standardized questionnaires and tests will be performed.
Discussion: The main aim of the cohort study is to monitor the course of the illness process and
to analyse for which reasons medical conditions are stable, deteriorating or only temporarily
present. First, clusters of combinations of diseases/disorders (multimorbidity patterns) with a
comparable impact (e.g. on quality of life and/or functional status) will be identified. Then the
development of these clusters over time will be analysed, especially with regard to prognostic
variables and the somatic, psychological and social consequences as well as the utilization of health
care resources. The results will allow the development of an instrument for prediction of the
deterioration of the illness process and point at possibilities of prevention. The practical
consequences of the study results for primary care will be analysed in expert focus groups in order
to develop strategies for the inclusion of the aspects of multimorbidity in primary care guidelines.
Background
Multimorbidity is a highly frequent condition in older
people that is supposed to significantly affect the patients'
quality of life, functional status and life expectancy. But
multimorbidity also is a complex phenomenon with an
almost endless number of possible disease combinations
of unclear implications. Therefore, it is not surprising that
there is only marginal evidence on the causes and impact
of multimorbidity today. To make things even more com-
plex, there is a wide diversity in definitions and criteria of
multimorbidity and there are many different measure-
ment instruments and considerable differences in popula-
tions investigated [1].
Findings on the prevalence of multimorbidity are not con-
sistent. A recent review by Marengoni of 33 population
based studies published between 1989 and 2007 found
prevalence rates in older people ranging from 21% to 98%
[2]. Another review by Fortin et al. found rates of multi-
morbidity between 50 to 100% [3]. In both reviews, the
ranges were due to differences in data sources, age groups
investigated and the definitions of multimorbidity used.
In contrast to a larger number of cross-sectional epidemi-
ological data, well designed longitudinal studies on the
impact of multimorbidity on patients and the health care
system have been remarkably scarce in numbers. The
effect of multimorbidity was investigated in a review by
Gijsen et al. [4]. According to these autors, multimorbid-
ity was significantly associated with higher mortality,
increased disability, a decline of functional status and a
lower quality of life. Multimorbidity was also associated
with an increase in health care utilization, i.e. number of
physician encounters, rate of hospitalization, length of
hospital stay, drug intake and costs [4,5]. Several studies
also suggest an interrelation between mental and somatic
disorders in multimorbidity clusters [6] and a protective
effect of psychosocial resources of the patient [7].
There is a widespread consensus that actual health care
delivery may not correspond to the needs of patients with
multimorbidity. The central medical professional for the
care and management of multiple chronic diseases is the
GP. This is related to his broad expertise but also to the
usually long-standing relationship to older patients. How-
ever, there is little help for the GP concerning the treat-
ment of patients with multimorbidity. At present, clinical
practice guidelines are mostly focussed on one disease
only. Although adhering to current clinical practice guide-
lines in the treatment of multimorbidity may therefore
even have adverse effects, the GP is widely left alone in
adjusting the care for these patients [8]. In general, the
diversity of results in studies on multimorbidity is not suf-
ficient to provide robust evidence for the care of patients
with multimorbidity [9].
In summary, the specific elements and processes in multi-
morbidity, the interactions and possible synergies of the
diseases within multimorbidity clusters are basically a
black box up to today. It remains unclear to which extent
single disease combinations and to which extent a gener-
alizable influence of multimorbidity contribute to the var-BMC Health Services Research 2009, 9:145 http://www.biomedcentral.com/1472-6963/9/145
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ious outcomes [4]. Also, how multimorbidity develops
over time is largely unknown.
The wide variety of possible disease combinations with
diverse impacts on the patient makes it difficult to tackle
the phenomenon of multimorbidity. In our approach, we
will try to discern a limited number of groups of disease
combinations ("multimorbidity patterns") with compara-
ble impact (e.g. on quality of life and/or functional sta-
tus). The statistical analyses will take the different
multimorbidity patterns into account.
As a result of these considerations, the aims of the study
are to:
￿ identify clusters of combinations of diseases/disor-
ders (multimorbidity patterns) in the elderly general
practice population and to determine their frequency
and severity in relation to each other;
￿ investigate the development of these clusters over
time (12 years), especially with regard to the internal
interaction between the diseases within the cluster
(addition, synergism, buffer, protection);
￿ analyse the relationship of mental and somatic dis-
orders in these patterns;
￿ identify prognostic variables for the course of spe-
cific multimorbidity patterns;
￿ investigate the somatic, psychological and social
consequences of multimorbidity (patterns) for the
patient's quality of life and functional status; and
￿ describe the utilization of health care resources and
the costs of care of multimorbidity (patterns).
Methods/Design
Design of the study
The study is designed as a multicentre, prospective, obser-
vational cohort study of 3.050 patients from general prac-
tice. The patients will be recruited from GP surgeries in 8
study centers distributed across Germany (Bonn, Düssel-
dorf, Frankfurt/Main, Hamburg, Jena, Leipzig, Mannheim
and Munich). In each surgery, 50 eligible patients will be
contacted and asked to participate in the study. All con-
tacted patients who are willing to participate will be
included in the study. As we estimate a rate of positive
responses between 40 and 50%, approx. 120 to 150 GP
surgeries have to be recruited consecutively. Each study
center will recruit 435 patients with the exception of
Frankfurt/Main and Jena, which will recruit 220 patients
each. This equates to 18 GP surgeries with 24 patients
each in every study center (9 GP surgeries in Frankfurt and
Jena respectively).
The study centers began to recruit GPs in July 2008. Sub-
sequently patient recruitment and data collection at base-
line started in the same month. It is projected to perform
a total of 9 waves of data collection by means of both GP
and patient interviews. Each wave will take 15 months to
be accomplished.
Sample Size
Due to the investigation of multiple outcomes and the
observational character of the study, there is no issue of
statistical power to be considered. Nevertheless, we can
derive from our experience with the similarly designed
AgeCoDe-study that a sample size of 3.050 patients can be
managed well in 8 study centres and will allow valid mul-
tivariate data analysis [10]. We expect a drop-out rate of
10% from baseline to first follow-up and a drop-out rate
of 5% for all other consecutive waves.
Inclusion of participants
Participating GPs will retrieve a list of all patients born
between 1.7.1923 and 30.6.1943 who have consulted
them within the last completed quarter (i.e. 3 month
period). Out of all eligible patients from this list 50
patients will be selected at random (using random
number tables) and invited to participate in the study by
a letter from their GP. In case of interest, the patient will
consult the GP and receive written and oral information.
The information covers aims and procedures of the study,
selection of participants, data collection, processing and
storage as well as possibilities for cancellation. In case of
acceptance, participants will have to sign an informed
consent form to participate in the study. For each surgery,
recourse and number of excluded patients per exclusion
criteria will be documented. We will estimate the actual
selection bias from age, gender and morbidity data.
Participants will be interviewed at all follow-ups by the
same interviewer, if possible. This personal relationship is
supposed to reduce the possibility of loss to follow-up.
From follow-up 1 on, each participant will be asked to
designate a contact person allowed to give information in
the case the participant cannot be contacted. In case of
drop out we will register the reason why (e.g. death, relo-
cation, cancellation of participation in study etc.).
Exclusion criteria
￿ Residence in a nursing home (inappropriateness for
longitudinal studies because of an average life expect-
ancy of 6 months after institutionalization).
￿ Severe illness probably lethal within three months
according to the GP.BMC Health Services Research 2009, 9:145 http://www.biomedcentral.com/1472-6963/9/145
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￿ Insufficient ability to speak and read German.
￿ Insufficient ability to consent (e.g. dementia).
￿ Insufficient ability to participate in interviews (e.g.
blindness, deafness).
￿ Poorly known patients to the GP because of acciden-
tal consultation.
￿ Participation in other studies at the present time.
Definition of multimorbidity
Multimorbidity is usually defined as the presence of two
or more chronic diseases at the same time. Two chronic
diseases are present in almost all people aged 65 years or
older. In order to enrich the sample, we therefore decided
to include only patients with at least three chronic condi-
tions. Furthermore, single diseases are unequally distrib-
uted within the multimorbidity spectrum. For example,
hypertension, hyperlipidemia and low back pain are
present in between 50 and 75% of these age groups
according to our (unpublished) analysis of the data of the
Gmünder ErsatzKasse, a German statutory health insur-
ance with 1.5 million members.
An unselected application of the three-disease-criterion
would have resulted in an overrepresentation of these very
frequent diseases in the study population. This would
have led to little interest of the medical community in the
results, as practical conclusions would have been limited
to a very small number of patterns.
In order to ensure a wide range of diseases and syn-
dromes, those with a prevalence of more than 25% were
not used for inclusion into the sample. Nevertheless, these
highly prevalent entities are frequently combined with the
relatively lower prevalent ones and therefore still part of
the sample. All diseases (including those not used for
patient inclusion, e.g. hypertension) are registered in the
morbidity spectrum of the patients and accounted for in
the pattern analysis in order to obtain a complete picture
of the diseases/syndromes in a patient.
Disease list for inclusion (ICD10 Codes in brackets)
￿ alcohol abuse; alcoholic liver disease
(F10;K70;K76);
￿ anaemia (D63-D64);
￿ anxiety disorders (F40-F41);
￿ arthrosis (excludes: osteoarthritis of spine) (M15-
M19);
￿ atherosclerosis; intermittent claudication
(I70;I73.9);
￿ cardiac arrhythmia (I44-I49);
￿ chronic ischemic heart disease; angina pectoris
(I20;I25);
￿ chronic lower respiratory diseases (J40-J47);
￿ chronic stroke; transient cerebral ischemic attack;
impaired cerebral blood flow (I60-I64;I67;I69;G45);
￿ chronic thyroid disorders; goitre (E01-E05;E06.1-
E06.3;E06.5;E06.9;E07);
￿ depressive disorders (F32-F33);
￿ diabetes mellitus (E10-E14);
￿ disorders of vestibular function; dizziness and giddi-
ness (H81;R42);
￿ diverticular intestinal disease (K57);
￿ hearing loss (H90-H91);
￿ heart failure (I50);
￿ malignant tumours (C00-C26;C30-C41;C43-
C58;C60-C97;D00-D09;D37-D48);
￿ migraine (G43);
￿ neuropathies (G50-G64);
￿ non-rheumatic mitral valve or aortic valve disorders
(I34-I35);
￿ osteoporosis (M80-M82);
￿ parkinson's disease (G20);
￿ psoriasis (L40);
￿ renal failure (N18-N19);
￿ rheumatoid arthritis; other soft tissue disorders
(M05-M06;M79);
￿ somatoform disorders (F45);
￿ urinary incontinence (N39.3-N39.4;R32);
￿ varicose veins of lower extremities (I83);BMC Health Services Research 2009, 9:145 http://www.biomedcentral.com/1472-6963/9/145
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￿ visual disturbances (H25-H26;H28;H33-
H36;H40;H43;H47;H53-H54).
Documentation of multimorbidity
The morbidity of the patients will be registered via chart
review, GP-interviews and patient interviews.
Chart review
For the last quarter, all ICD10 diagnoses from patients'
charts in the GP documentation system will be retrieved
for all recruited patients.
GP interview
The GP will provide the disease spectrum of the patient by
means of a standardized documentation instrument
which covers:
1. all diseases described above (amended during fol-
low-up data collection for chronic indications fre-
quently mentioned in the open questions in previous
waves);
2. neoplasms under 14 ICD10 subject headings;
3. mental and behavioral disorders under 11 ICD10
subject headings;
4. two open questions regarding further chronic and
acute conditions not mentioned in the chronic dis-
eases list.
For each illness, the GP will indicate duration (presence
since how many years) and severity (regarding prognosis
and subjective burden) on a Likert-type scale ranging from
0 = marginal to 4 = very severe.
Patient interview
A similar list of diseases will be used in patient interviews,
with the following modifications:
￿ due to the lack of comparison possibilities for the
patient, the severity of the single diseases will not be
rated by the patient;
￿ ICD-based psychic diseases are not included in the
patient list. Assessment of the psychic situation of the
patient from his/her view will be done with the fol-
lowing screening tests:
1. a culturally adapted version of the Four Dimen-
sional Symptom Questionnaire (4DSQ) [11] for
depression, anxiety, somatization and distress in
primary care patients;
2. the Geriatric Depression Scale (GDS) [12];
3. the presence of cognitive disorders is assessed
with the Clinical Dementia Rating (CDR) [13].
As a part of the patient interview a complete medication
survey will be performed. The interviewer will collect data
on all pharmaceutical products used by the patient within
the last three months. The data include product name,
pharmaceutical form, German national drug code ("Phar-
mazentralnummer" – PZN-), periodic or prn (pro re nata)
medication, dosage and frequency (for periodic medica-
tion). The interviewer will ask the patient to show the
packages of the pharmaceuticals to get the most valid
information. If product name and drug code are not avail-
able, the patient will be asked for the medical indication
of the drugs.
The total burden of morbidity will be measured by several
multimorbidity indices, which will be automatically cal-
culated from the disease data collected in the GP inter-
views and data on medication from patient interviews
respectively:
￿ the count of the number of chronic conditions [14],
without taking the disease severity in account
(Unweighted Disease Count);
￿ the total number of chronic conditions weighted by
disease severity as rated in GP interview (Weighted
Disease Count);
￿ the diagnosis-related comorbidity score developed
by Charlson et al. (Charlson Index) [15];
￿ the Cumulative Illness Rating Scale for Geriatrics
(CIRS-G) [16], a multimorbidity index based on dis-
ease severity grouped at organ system levels;
￿ the medication-based chronic disease score devel-
oped by Von Korff et al. (Von Korff Index) [17].
The different indices will be compared regarding their pre-
dictive values.
The interviewers will also collect the following data about
the attending GPs and GP surgeries:
￿ number of attending doctors in surgery;
￿ number of patients per doctor;
￿ location of surgery;
￿ age, gender and specialty of attending doctor;
￿ date of setting up of the surgery.BMC Health Services Research 2009, 9:145 http://www.biomedcentral.com/1472-6963/9/145
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The patient interviews will contain an assessment of
health care utilization. The questionnaire was developed
on the basis of cost diaries used in earlier studies [18]. A
random sample of 1/3 of the patients will be asked to give
extensive information about the following data, whereas
the other 2/3 will receive a short version:
￿ number of hospitalizations and of hospital days;
￿ number of contacts with GPs, specialists and den-
tists;
￿ prescriptions of therapeutic measures (e.g. physio-
therapy);
￿ stage of nursing needs (according to the Statutory
Nursing Insurance);
￿ utilization of nursing services.
Variables under study
The variables under study belong to four groups: morbid-
ity (as described above), functional status, resources/risk
factors and socio-demographic data. The domain of func-
tional status includes activities and instrumental activities
of daily living, motor skills, senses (i.e. hearing and
vision), cognition, pain and health-related quality of life.
Resources include physical activity, balanced nutrition,
social support, general self-efficacy, utilization of medical
services and the quality of medical care according to the
Chronic Care Model [19]. Risk factors include physical
inactivity, malnutrition, alcohol abuse, smoking, body-
mass-index and waist-to-hip-ratio. Socio-demographic
variables include age, gender, migrant status, marital sta-
tus, living conditions, household size, education, former
occupation, income and wealth.
Table 1 gives an overview of the variable groups, and the
measuring instruments and data sources for the variables.
The instruments were chosen according to comprehen-
siveness, established reliability and validity, appropriate-
ness for the age group ≥ 65 years, understandability and
ease of administration in face-to-face interviews.
Visual aids with possible response options will guide
interviewees in the different standardized questionnaires.
For each interviewer, age, gender, experience, and profes-
sional background will be documented to assess (and sta-
tistically control for) interviewer effects.
Quality assurance
Procedures for prevention of insufficient data quality,
detection of inaccurate or incomplete data and actions to
improve data quality will be performed, e.g. user reliabil-
ity trainings, automatic plausibility and integrity checks
and data error reports to the collaborating centers. The
centers will receive feedback by quality reports for which
the indicators of the national guidelines of the TMF-
project ("telematics platform for medical research net-
works") for data quality will be applied. These quality
controls will be conducted by the Institute for Biometry of
Hannover Medical School. For every survey wave, the
Institute will conduct a source data validation of a 1% ran-
dom sample of all questionnaires to calculate input data
errors.
Data security
The interviews will be performed by trained scientists and
study nurses at the patients' homes and for the GPs in
their surgeries using printed forms. Regular training ses-
sions will be performed twice each year. An email list
server will be used for clarification of not anticipated
assessment problems. Survey sheets and patient contact
sheets will be stored in separate lockers in the study cent-
ers. Data will be entered in the local centers via an internet
based remote data entry system. The data are transferred
via 128 bit SSL encryption. The data will be stored in a
central database in the Institute for Biometry of Hannover
Medical School. The access to the internal database and
web server is controlled by two consecutive firewall sys-
tems. A pseudonym will be automatically created when
the identification data are entered and a printed copy with
the pseudonym and the identification data will be
archived by an officiating notary ("data trustee"). The
identification data will neither be electronically trans-
ferred nor stored. The members of the study group will
have access to the electronic data entry system according a
detailed concept of roles and rights. An audit trail will
ensure an automatic protocol of all data entries, changes
and deletions.
Description of risks
It is not expected that participation in the study will
expose the patients to any risks. Nevertheless, monitoring
of the impact of the study on patients will be performed
by the interviewers and counseling given in case partici-
pants experience any discomfort or harm.
Ethics approval
The study is conducted in compliance with the Helsinki
Declaration. The study protocol was approved by the Eth-
ics Committee of the Medical Association of Hamburg in
February 2008 and amended in November 2008
(Approval-No. 2881).
Data Analysis
Cross-sectional analysis
Recruitment and baseline data will be used to develop sta-
tistical models that relate the independent variables to the
dependents:BMC Health Services Research 2009, 9:145 http://www.biomedcentral.com/1472-6963/9/145
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￿ Multimorbidity patterns of similar severity will be
identified by methods of supervised learning (meth-
ods of recursive partitioning like CART [Classification
and Regression Trees], logistic regression).
￿ We will conduct different regression modelling strat-
egies [20]. The basic model for each dependent will
contain the independents as regressors, and interac-
tions between them.
￿ Mixed models will be applied allowing to take the
GP-induced cluster structure into account.
￿ The correspondence of GP-rated and patient-rated
data will be analysed using inter-rater-reliability
(Cohen's kappa).
Longitudinal analysis
￿ Based on the results of the cross-sectional analysis,
hypotheses will be formulated as far as the individual
outcomes (dependents) at the end of the follow-up
period are concerned. Predictive scores will be calcu-
lated [21].
￿ As soon as the follow-up data are available, mixed
models which include the baseline variables will be
Table 1: Variables, measuring instruments and data sources
Morbidity Measuring instrument Data source
Diagnoses ICD-10 codes chart review
Diseases self-developed questionnaire GP interview
self-developed questionnaire patient interview
Four-Dimensional Symptom Questionnaire (4DSQ) [11] patient interview
Geriatric Depression Scale (GDS) [12] patient interview
Clinical Dementia Rating (CDR) [13] rated by interviewer
Functional Status
Activities of daily living Barthel Index [22] patient interview
Instrumental Activities of Daily Living (IADL) Scale [23] patient interview
Motor skills FFB-Mot [24] patient interview
Vision and hearing 2 items rated on a 4 point scale patient interview
Cognitive impairment CERAD [25] subtests word list and animal naming cognitive tests by interviewer
Letter Digit Substitution Test (LDST) [26] cognitive tests by interviewer
Pain Graded Chronic Pain Scale (GCPS) [27] patient interview
Health-related quality of life EuroQoL (EQ-5D) Scale [28] patient interview
Resources/Risk Factors
Physical risk factors Body-Mass-Index and Waist-to-Hip-Ratio physical checkup by GP
Physical activity International Physical Activities Questionnaire (IPAQ) [29] patient interview
Nutrition 12 items for frequency and portion size of nutriments patient interview
Alcohol use AUDIT-C [30] patient interview
total amount of alcohol consumption per week patient interview
Smoking behavior 9 items indicating current smoking status and pack years patient interview
General self-efficacy General Self-efficacy Scale [31] patient interview
Social support F-SOZU K14 [32] patient interview
Medical care Patient Assessment of Chronic Illness Care (PACIC) [33] patient interview at baseline
age and gender of GP/size and location of surgery GP interview
Utilization of medical services (incl. medication) 15 items (short form), respectively 91 items (long form) patient interview
Sociodemographic Data
Age and gender age and gender chart review
Migrant status standardised indicators for mapping migrant status [34] patient interview at baseline
Marital status marital status patient interview
Living conditions independent or assisted living patient interview
Household size household size/household members under 15 years patient interview
Education CASMIN classification [35] patient interview at baseline
Former occupation German epidemiological standard questionnaire [36] patient interview at baseline
Income household size adjusted net income patient interview
Wealth home ownership patient interviewBMC Health Services Research 2009, 9:145 http://www.biomedcentral.com/1472-6963/9/145
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fitted for the follow-up data or the changes from base-
line, respectively.
￿ Structural equation modeling will be applied to map
causal chains between dependents.
￿ A classification system will be derived which groups
patients as they are comparable with respect to inten-
sity of care and costs.
Discussion
The project will be the first large scale and longitudinal
investigation of multimorbidity in Germany based on a
cohort of multimorbid patients randomly selected from
general practice data bases. The project will help to discern
distinct multimorbidity patterns and identify variables
associated with these patterns. A better understanding of
the individual variability in the process of multimorbidity
is necessary for a better quality of medical care, better sup-
port of patients' self management and a more effective
and efficient allocation of resources.
Therefore, the main aim of the cohort study is to monitor
the course of the illness process and to analyse for which
reasons medical conditions are stable, deteriorating or
only temporarily present. The results will allow the devel-
opment of an instrument for prediction of the deteriora-
tion of the illness process and point at possibilities of
prevention.
The practical consequences of the study results for pri-
mary care will be analysed in expert focus groups of GPs
and nurses, supplemented by further experts (e.g. geriatri-
cians). The aim is to develop strategies for the inclusion of
the aspects of multimorbidity in primary care guidelines.
This will include:
￿ rating of existing guidelines with regard to their
(in)appropriateness for primary care;
￿ prioritization of multimorbidity patterns according
to the needs for specific guidelines;
￿ needs for special services for patients with multimor-
bidity (e.g. improvement of the existing education
programs; possibilities and limits of multimorbidity
oriented disease management programs).
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